查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1957813

2026年全球體細胞基因檢測市場報告

Somatic Genetic Testing Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，體細胞基因檢測市場發展迅速。預計該市場規模將從2025年的77.8億美元成長到2026年的88.8億美元，複合年成長率（CAGR）為14.1%。過去幾年成長要素包括：基因檢測普及率有限、對傳統診斷方法的依賴、人們對癌症體細胞突變的認知不斷提高、醫院和臨床實驗室基礎設施的擴建以及對研究機構投資的增加。

預計未來幾年體細胞基因檢測市場將快速成長，到2030年將達到149.2億美元，複合年成長率（CAGR）為13.9%。預測期內的成長要素包括：次世代定序（NGS）和多體學技術的進步、家庭和臨床定序服務的擴展、精準醫療舉措的推進、政府對基因檢測計畫的投入增加，以及基於人工智慧的突變解讀分析技術的整合。預測期內的關鍵趨勢包括：針對癌症和罕見疾病的標靶基因檢測panel的廣泛應用、次世代定序（NGS）技術的日益普及、個人化和精準癌症治療的發展、家庭基因檢測解決方案的擴展，以及多體學數據在臨床決策中的應用。

癌症發生率的激增預計將推動體細胞基因檢測市場的成長。癌症是一組疾病，其特徵是異常細胞在體內不受控制地增生和擴散。這種成長趨勢歸因於營養不良、吸煙、缺乏運動和過度飲酒等生活方式因素。體細胞基因檢測透過識別腫瘤特異性突變來輔助癌症診斷，從而實現精準的個人化治療。它利用最尖端科技減少了侵入性檢查，提高了檢測的可靠性，並為患者提供了有益的結果。例如，加拿大癌症協會（總部位於加拿大的國家級癌症組織）在2023年11月預測，2023年將有239,100例新增癌症病例和約86,700例死亡病例。因此，癌症發生率的上升正在推動體細胞基因檢測市場的發展。

體細胞基因檢測市場的主要企業正在開發液態生物檢體等診斷工具，以提高檢測準確性、實現早期發現並避免侵入性手術。液態生物檢體無需手術即可分析血液中的循環腫瘤DNA (ctDNA) 和生物標記物，從而檢測癌症相關突變。例如，2024年9月，總部位於印度的基因組學和生物資訊學公司Strand Life Sciences推出了Somatic Advantage 74液態生物檢體(SA74 LB) 檢測，這是一種用於檢測血液中ctDNA的先進液態生物檢體技術。此檢測採用次世代定序(NGS) 技術，分析74個關鍵癌基因中的體細胞突變。它無需組織取樣即可識別可治療的突變、追蹤治療效果並檢測微量殘存疾病(MRD)，從而實現個人化癌症治療。該檢測可用於標靶藥物選擇以及進展和抗藥性的即時監測。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球體細胞基因檢測市場：吸引力評分與分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 生物技術、基因組學和精準醫療
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物聯網、智慧基礎設施、互聯生態系統
  • 主要趨勢
    • 針對癌症和罕見疾病的標靶基因檢測方法正在不斷推廣應用
    • 擴大次世代定序（NGS）技術的應用
    • 個人化和精準癌症治療的發展
    • 家用基因檢測解決方案的擴展
    • 整合多體學資料用於臨床決策

第5章 終端用戶產業市場分析

  • 醫院
  • 臨床檢查室
  • 研究機構
  • 家庭檢測服務提供者
  • 生物製藥公司

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球體細胞基因檢測市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球體細胞基因檢測市場規模、對比及成長率分析
  • 全球體細胞基因檢測市場表現：規模與成長，2020-2025年
  • 全球體細胞基因檢測市場預測：規模與成長，2025-2030年，2035年預測

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按類型
  • 標靶基因panel檢測、全EXOME定序、全基因組定序及其他檢測方法
  • 檢體
  • 組織標本、血液標本、骨髓穿刺標本及其他檢體
  • 透過技術
  • 聚合酵素鏈鎖反應（PCR）、次世代定序（NGS）、微陣列、桑格定序及其他技術
  • 透過使用
  • 癌症診斷、心血管疾病、神經系統疾病及其他應用領域
  • 最終用戶
  • 醫院、臨床檢查室、研究機構和其他最終用戶
  • 按類型細分：目標基因面板
  • 腫瘤科專家組、神經科專家組、心血管科專家組、罕見疾病專家組、藥物基因學專家組
  • 按類型細分：全EXOME顯子定序
  • 全EXOME定序用於診斷、全EXOME定序用於臨床研究、基於人群的全EXOME定序
  • 按類型細分：全基因組定序
  • 臨床全基因組定序、研究性全基因組定序、從頭全基因組定序、癌症全基因組定序
  • 按類型細分：其他測試方法
  • 拷貝數變異檢測、粒線體去氧核糖核酸（DNA）檢測、核糖核酸（RNA）定序、表觀遺傳學檢測

第10章 區域與國別分析

  • 全球體細胞基因檢測市場：依地區分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測
  • 全球體細胞基因檢測市場：依國家分類，實際結果與預測，2020-2025年、2025-2030年預測、2035年預測

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 體細胞基因檢測市場：競爭格局及市場佔有率（2024年）
  • 體細胞基因檢測市場：公司估值矩陣
  • 體細胞基因檢測市場：公司概況
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Laboratory Corporation of America Holdings
    • Quest Diagnostics Incorporated
    • Agilent Technologies Inc.

第37章 其他大型企業和創新企業

  • Illumina Inc., QIAGEN NV, Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc.

第38章：全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章：高潛力市場國家、細分市場與策略

  • 2030年體細胞基因檢測市場：提供新機會的國家
  • 2030年體細胞基因檢測市場：新興細分市場機會
  • 2030年體細胞基因檢測市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第41章附錄

簡介目錄
Product Code: PH5MSGTE02_G26Q1

Somatic genetic testing involves the detailed analysis of genetic mutations that develop in non-reproductive (somatic) cells during a person's lifetime, most commonly in tumor tissues. This testing is essential in cancer diagnosis and treatment, as it identifies specific genetic alterations that can be targeted with personalized therapies, helping to predict disease progression and guide clinical decisions.

The main types of somatic genetic testing are targeted gene panels, whole exome sequencing, whole genome sequencing, carrier screening, and others. Targeted gene panels focus on analyzing a specific set of genes linked to a particular disease or condition, enabling precise and cost-effective diagnosis. Samples for testing include tissue-based, blood-based, bone marrow aspirates, and others, utilizing advanced technologies such as polymerase chain reaction (PCR), next-generation sequencing (NGS), microarray, Sanger sequencing, and more. This testing is applied in cancer diagnosis, cardiovascular disorders, neurological disorders, inherited genetic disorders, and other areas, serving end users such as hospitals, clinical laboratories, research institutes, at-home testing providers, and more.

Tariffs have impacted the somatic genetic testing market by increasing costs of imported sequencing instruments, reagents, and consumables used in PCR, NGS, and microarray technologies. Segments like whole genome sequencing and targeted gene panels are most affected, particularly in North America and Europe, which rely heavily on imported high-tech equipment. This has resulted in higher operational costs and potential delays in testing services. On the positive side, tariffs have encouraged local manufacturing, investment in domestic sequencing infrastructure, and development of cost-efficient testing solutions.

The somatic genetic testing market research report is one of a series of new reports from The Business Research Company that provides somatic genetic testing market statistics, including somatic genetic testing industry global market size, regional shares, competitors with a somatic genetic testing market share, detailed somatic genetic testing market segments, market trends and opportunities, and any further data you may need to thrive in the somatic genetic testing industry. This somatic genetic testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The somatic genetic testing market size has grown rapidly in recent years. It will grow from $7.78 billion in 2025 to $8.88 billion in 2026 at a compound annual growth rate (CAGR) of 14.1%. The growth in the historic period can be attributed to limited access to genetic testing, reliance on conventional diagnostic methods, growing awareness of somatic mutations in cancer, increasing hospital and clinical laboratory infrastructure, rising investment in research institutes.

The somatic genetic testing market size is expected to see rapid growth in the next few years. It will grow to $14.92 billion in 2030 at a compound annual growth rate (CAGR) of 13.9%. The growth in the forecast period can be attributed to advancements in ngs and multi-omics technologies, expansion of at-home and clinical sequencing services, increasing precision medicine initiatives, rising government funding for genetic testing programs, integration of ai-based analytics for mutation interpretation. Major trends in the forecast period include rising adoption of targeted gene panels for cancer and rare diseases, increasing use of next-generation sequencing (ngs) technologies, growth in personalized and precision oncology treatments, expansion of at-home genetic testing solutions, integration of multi-omics data for clinical decision-making.

The escalating cancer incidence is poised to drive the somatic genetic testing market forward. Cancer encompasses disorders defined by rampant, spreading abnormal cells throughout the body. This growing burden stems from lifestyle factors like suboptimal nutrition, tobacco use, lack of exercise, and heavy drinking. Somatic genetic testing supports cancer diagnosis by pinpointing tumor-specific mutations, facilitating precise, individualized therapies. It curbs invasive methods through cutting-edge tools, enhancing detection reliability and patient results. For example, in November 2023, the Canadian Cancer Society, a Canada-based national cancer organization, projected 239,100 new diagnoses and about 86,700 deaths in 2023. Thus, the rising cancer incidence is fueling the somatic genetic testing market.

Prominent companies in the somatic genetic testing market are advancing diagnostic tools like liquid biopsy tests to sharpen precision, enable early spotting, and sidestep invasive steps. Liquid biopsy tests offer non-surgical analysis of circulating tumor DNA (ctDNA) or biomarkers in blood to uncover cancer-linked mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics firm, introduced the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a state-of-the-art liquid biopsy for ctDNA detection from blood. This NGS-driven assay scans somatic alterations in 74 critical cancer genes. It empowers tailored oncology by flagging treatable mutations, tracking therapy effects, and spotting minimal residual disease (MRD) minus tissue sampling. The test guides targeted drugs and real-time progression or resistance surveillance.

In June 2023, Genomenon Inc., a US healthcare tech company, acquired Boston Genetics Inc. for an undisclosed sum. This merger amplifies Genomenon's goal to map the full human genome by fusing its AI-driven Mastermind platform with Boston Genetics' expert team, elevating genomic analysis for clinical testing and drug development. Boston Genetics Inc. is a US genomics firm expert in variant curation and annotation via specialist geneticists.

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the somatic genetic testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The somatic genetic testing market consists of revenues earned by entities by providing services such as tumor profiling, biomarker identification, companion diagnostic testing, mutation analysis, and next-generation sequencing (NGS) for personalized cancer therapy selection and treatment monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The somatic genetic testing market also includes sales of testing kits, reagents, assay panels, sequencing instruments, software tools for data analysis, and laboratory consumables used in the detection and interpretation of somatic mutations. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Somatic Genetic Testing Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses somatic genetic testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for somatic genetic testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The somatic genetic testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Targeted Gene Panels; Whole Exome Sequencing; Whole Genome Sequencing; Other Testing Methods
  • 2) By Sample: Tissue-Based; Blood-Based; Bone Marrow Aspirates; Other Samples
  • 3) By Technology: Polymerase Chain Reaction (PCR); Next-Generation Sequencing (NGS); Microarray; Sanger Sequencing; Other Technologies
  • 4) By Application: Cancer Diagnosis; Cardiovascular Disorders; Neurological Disorders; Other Applications
  • 5) By End-User: Hospitals; Clinical Laboratories; Research Institutes; Other End-Users
  • Subsegments:
  • 1) By Targeted Gene Panels: Oncology Panels; Neurology Panels; Cardiovascular Panels; Rare Disease Panels; Pharmacogenomics Panels
  • 2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing; Clinical Research Whole Exome Sequencing; Population-Based Whole Exome Sequencing
  • 3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing; Research Whole Genome Sequencing; De Novo Whole Genome Sequencing; Cancer Whole Genome Sequencing
  • 4) By Other Testing Methods: Copy Number Variation Testing; Mitochondrial Deoxyribonucleic Acid (DNA) Testing; Ribonucleic Acid (RNA) Sequencing; Epigenetic Testing
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Agilent Technologies Inc.; Illumina Inc.; QIAGEN N.V.; Exact Sciences Corp.; ARUP Laboratories Inc.; Natera Inc.; Myriad Genetics Inc.; Fulgent Genetics Inc.; Invitae Corporation; NeoGenomics Laboratories Inc.; Guardant Health Inc.; MedGenome Labs Ltd.; Caris Life Sciences Inc.; Oxford Nanopore Technologies Ltd.; Pacific Biosciences of California Inc.; Invivoscribe Inc.; Centogene N.V.; Circulogene Theranostics LLC.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Somatic Genetic Testing Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Somatic Genetic Testing Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Somatic Genetic Testing Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Somatic Genetic Testing Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Rising Adoption Of Targeted Gene Panels For Cancer And Rare Diseases
    • 4.2.2 Increasing Use Of Next-Generation Sequencing (NGS) Technologies
    • 4.2.3 Growth In Personalized And Precision Oncology Treatments
    • 4.2.4 Expansion Of At-Home Genetic Testing Solutions
    • 4.2.5 Integration Of Multi-Omics Data For Clinical Decision-Making

5. Somatic Genetic Testing Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Clinical Laboratories
  • 5.3 Research Institutes
  • 5.4 At-Home Testing Providers
  • 5.5 Biopharmaceutical Companies

6. Somatic Genetic Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Somatic Genetic Testing Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Somatic Genetic Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Somatic Genetic Testing Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Somatic Genetic Testing Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Somatic Genetic Testing Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Somatic Genetic Testing Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Somatic Genetic Testing Market Segmentation

  • 9.1. Global Somatic Genetic Testing Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods
  • 9.2. Global Somatic Genetic Testing Market, Segmentation By Sample, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples
  • 9.3. Global Somatic Genetic Testing Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies
  • 9.4. Global Somatic Genetic Testing Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications
  • 9.5. Global Somatic Genetic Testing Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Clinical Laboratories, Research Institutes, Other End-Users
  • 9.6. Global Somatic Genetic Testing Market, Sub-Segmentation Of Targeted Gene Panels, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels
  • 9.7. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Exome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing
  • 9.8. Global Somatic Genetic Testing Market, Sub-Segmentation Of Whole Genome Sequencing, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing
  • 9.9. Global Somatic Genetic Testing Market, Sub-Segmentation Of Other Testing Methods, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

10. Somatic Genetic Testing Market Regional And Country Analysis

  • 10.1. Global Somatic Genetic Testing Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Somatic Genetic Testing Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Somatic Genetic Testing Market

  • 11.1. Asia-Pacific Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Somatic Genetic Testing Market

  • 12.1. China Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Somatic Genetic Testing Market

  • 13.1. India Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Somatic Genetic Testing Market

  • 14.1. Japan Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Somatic Genetic Testing Market

  • 15.1. Australia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Somatic Genetic Testing Market

  • 16.1. Indonesia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Somatic Genetic Testing Market

  • 17.1. South Korea Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Somatic Genetic Testing Market

  • 18.1. Taiwan Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Somatic Genetic Testing Market

  • 19.1. South East Asia Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Somatic Genetic Testing Market

  • 20.1. Western Europe Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Somatic Genetic Testing Market

  • 21.1. UK Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Somatic Genetic Testing Market

  • 22.1. Germany Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Somatic Genetic Testing Market

  • 23.1. France Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Somatic Genetic Testing Market

  • 24.1. Italy Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Somatic Genetic Testing Market

  • 25.1. Spain Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Somatic Genetic Testing Market

  • 26.1. Eastern Europe Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Somatic Genetic Testing Market

  • 27.1. Russia Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Somatic Genetic Testing Market

  • 28.1. North America Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Somatic Genetic Testing Market

  • 29.1. USA Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Somatic Genetic Testing Market

  • 30.1. Canada Somatic Genetic Testing Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Somatic Genetic Testing Market

  • 31.1. South America Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Somatic Genetic Testing Market

  • 32.1. Brazil Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Somatic Genetic Testing Market

  • 33.1. Middle East Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Somatic Genetic Testing Market

  • 34.1. Africa Somatic Genetic Testing Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Somatic Genetic Testing Market, Segmentation By Type, Segmentation By Sample, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Somatic Genetic Testing Market Regulatory and Investment Landscape

36. Somatic Genetic Testing Market Competitive Landscape And Company Profiles

  • 36.1. Somatic Genetic Testing Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Somatic Genetic Testing Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Somatic Genetic Testing Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Quest Diagnostics Incorporated Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Somatic Genetic Testing Market Other Major And Innovative Companies

  • Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc.

38. Global Somatic Genetic Testing Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Somatic Genetic Testing Market

40. Somatic Genetic Testing Market High Potential Countries, Segments and Strategies

  • 40.1 Somatic Genetic Testing Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Somatic Genetic Testing Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Somatic Genetic Testing Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer